Therefore, it is believed that the downregulated expression level of ANXA1 in drug-resistant cell lines leads to a decrease in tumour cell apoptosis, which further reduces the sensitivity of tumour cells to drugs and leads to resistance [6]. The gene discussed is ANXA1; the disease is neoplasm.